Omnicell, Inc. (NASDAQ:OMCL) Receives Average Recommendation of “Hold” from Brokerages
Omnicell, Inc. (NASDAQ:OMCL – Get Free Report) has received a consensus recommendation of “Hold” from the six brokerages that are currently covering the firm, Marketbeat Ratings reports. Four research analysts have rated the stock with a hold recommendation and two have issued a buy recommendation on the company. The average 1-year price objective among brokers […]
More Stories
Revance Therapeutics (NASDAQ:RVNC) Research Coverage Started at StockNews.com
StockNews.com began coverage on shares of Revance Therapeutics (NASDAQ:RVNC – Free Report) in a research report report published on Sunday....
OptimumBank (NASDAQ:OPHC) Research Coverage Started at StockNews.com
StockNews.com initiated coverage on shares of OptimumBank (NASDAQ:OPHC – Free Report) in a research note published on Sunday morning. The...
Ayala Pharmaceuticals (NASDAQ:ADXS) Earns Sell Rating from Analysts at StockNews.com
StockNews.com assumed coverage on shares of Ayala Pharmaceuticals (NASDAQ:ADXS – Free Report) in a report released on Sunday morning. The...
Avinger (NASDAQ:AVGR) Research Coverage Started at StockNews.com
StockNews.com assumed coverage on shares of Avinger (NASDAQ:AVGR – Free Report) in a report published on Sunday morning. The firm...
AppFolio (NASDAQ:APPF) Rating Lowered to Neutral at Piper Sandler
AppFolio (NASDAQ:APPF – Get Free Report) was downgraded by equities research analysts at Piper Sandler from an “overweight” rating to...
Ricky Sandler Sells 915,603 Shares of Entain Plc (LON:ENT) Stock
Entain Plc (LON:ENT – Get Free Report) insider Ricky Sandler sold 915,603 shares of the business’s stock in a transaction...